MYC and Wilms tumor: Trifluoperazine is traditionally an antipsychotic but has recently been shown to have anticancer growth properties.24 In particular, it is believed to inhibit MYC-induced cell transformation.25 We hypothesize that trifluoperazine’s anti-cancer properties can therefore be used to treat cancers in which MYC is dysregulated, such as Wilms tumors.